Urokinase receptor surface expression regulates monocyte adhesion in acute myocardial infarction

Immunology and Microbiology

• Umbilical Vein Endothelial Cell 100%
• Urokinase Receptor 100%
• Integrin 100%
• Macrophage-1 Antigen 75%
• Lymphocyte Function-Associated Antigen 1 50%
• Monoclonal Antibody 50%
• Cell Adhesion 50%
• Upregulation 50%
• Mononuclear Cell 50%
• Fibrinogen 50%
• Blood Plasma 25%
• CD11a 25%
• Complex Formation 25%
• Intercellular Adhesion Molecule 1 25%
• CD18 25%
• Pre B Lymphocyte 25%

Keyphrases

• Soluble Urokinase Plasminogen Activator Receptor (suPAR) 100%
• Surface Expression 100%
• Acute Myocardial Infarction 100%
• Monocyte Adhesion 100%
• Adhesion 28%
• Integrin 28%
• Human Umbilical Vein Endothelial Cells (HUVECs) 28%
• Macrophages 21%
• Vitronectin 21%
• Fibrinogen 14%
• Cell Adhesion 14%
• Monoclonal Antibody 14%
• Mononuclear Cells 14%
• LFA-1 14%
• Incubation 7%
• Flow Cytometry 7%
• Functional Relevance 7%
• Direct Binding 7%
• Complementary DNA (cDNA) 7%
• Strong Correlation 7%
• Adhesiveness 7%
• B Lymphocytes 7%
• Soluble Factors 7%
• In Vitro System 7%
• Intercellular Adhesion molecule-1 (ICAM-1) 7%
• Monocytes 7%
• Monocytic 7%
• Messenger RNA Expression 7%
• CD18 7%
• Monocyte Recruitment 7%
• CD11a 7%
• Chronic Stable Angina 7%
• Anti-CD11b 7%

Pharmacology, Toxicology and Pharmaceutical Science

• Acute Heart Infarction 100%
• Urokinase Receptor 100%
• Integrin 50%
• Vitronectin 37%
• CD11b Antigen 37%
• Lymphocyte Function Associated Antigen 1 25%
• Monoclonal Antibody 25%
• Fibrinogen 25%
• Flow Cytometry 12%
• Intercellular Adhesion Molecule 1 12%
• CD18 Antigen 12%
• Stable Angina Pectoris 12%
• Complementary DNA 12%
• Messenger RNA 12%